Chromocell (CHRO) - Yalpi foyda normasi

Chromocell Therapeutics Corporation (CHRO) kompaniyasining rasmiy ramzlari

Laboratoriya testlarini robotlashtirilgan platforma orqali avtomatlashtirish dori vositalari sintezini tezlashtiradi. Valo martjasi joriy operatsion daromadlarni aks ettiradi, bunda 0.00 joriy parametr qiymati vazifasini bajaradi. Chromocell Therapeutics ion kanallarini nishonga oluvchi xavfsiz opioid bo'lmagan og'riq qoldiruvchi vositalarni ishlab chiqishga e'tibor qaratadi. Akademik madaniyat va aksiyalar opsion dasturlari Chromocell Therapeutics kompaniyasiga chuqur tadqiqotlar olib borish uchun yetakchi neyrobiologlarni jalb qilish imkonini beradi.

chromocell.com (CHRO) - Yalpi marja 21.02.2024dan 02.07.2025gacha

Chromocell Therapeutics (CHRO) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Fundamental baholash:Chromocell Therapeutics
Chromocell brend mahsuloti

Tadqiqot va ishlanmalar (R&D) bosqichidagi biotexnologiya startapi uchun investitsiyaviy jozibadorlik operatsion pul oqimi mavjud bo'lmagan holda zaxiralarni boshqarish samaradorligiga bog'liq. 0.00 ga teng bo'lgan yalpi marja bevosita ishlab chiqarish xarajatlari chegirib tashlanganidan keyingi foyda ulushini o'lchaydi va asosiy jarayonlarning samaradorligini aks ettiradi. Konsolidatsiyalashgan yalpi marja tahlili Chromocell Therapeutics (CHRO) kompaniyasining IPO mablag'lariga bog'liqligini hisobga olgan holda, mablag'larning sarflanish sur'ati (burn rate) va moliyaviy barqarorligini baholash imkonini beradi.

Asosiy raqobatchilar

Yalpi foyda bo'yicha rentabellik Biogen Corp|Yalpi foyda bo'yicha rentabellik NBIX|Regencell Corp (RGC) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja AXSM|Yalpi foyda bo'yicha rentabellik ACADIA Pharmaceuticals ACAD|Yalpi marja XENE (Xenon Pharmaceuticals Inc.)|VKTX (Viking Therapeutics, Inc.) - Yalpi foyda bo'yicha marjinallik|SUPN - Yalpi rentabellik|Catalyst Pharmaceuticals Inc (CPRX) - Yalpi foyda bo'yicha rentabellik|DNLI (Denali Corp) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi harmonybiosciences.com (HRMY)|Yalpi foyda bo'yicha rentabellik BHVN|Yalpi marja Amylyx|Yalpi marja TRVI|PRAX (Praxis Corp) - Yalpi foyda normasi|Yalpi marja AVXL (anavex.com)|CBLL: Sotuvning yalpi rentabelligi|PRTA - Yalpi rentabellik|ALEC - Yalpi marja|Annexon Inc. (ANNX) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Omeros Corp|Yalpi foyda bo'yicha rentabellik NGNE|ACIU: Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik VYGR (Voyager Corp)|Yalpi foyda bo'yicha rentabellik Neumora NMRA|Yalpi rentabellik Scilex Holding Company, Inc. SCLX|Sotuvning yalpi marjinal rentabelligi Tevogen Bio Inc.|ACOG - Yalpi rentabellik|Sotuvning yalpi marjinal rentabelligi Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Yalpi foyda bo'yicha rentabellik|Cassava Sciences Inc (SAVA) - Yalpi marja|Yalpi foyda bo'yicha rentabellik ASRT|Yalpi marja coyatherapeutics.com|Yalpi marja VTGN|Ovid Therapeutics - Sotuvning yalpi rentabelligi|Yalpi marja ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Yalpi foyda bo'yicha rentabellik|ATHE - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi clene.com CLNN|PEPG: Yalpi marja|Sotuvning yalpi rentabelligi JUNS|RLMD (Relmada Corp) - Yalpi marja|Annovis Bio Inc (ANVS) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Yalpi foyda normasi|Yalpi rentabellik Klotho Neurosciences KLTO|NRSN: Sotuvning yalpi rentabelligi|RVPH: Yalpi foyda bo'yicha rentabellik|MTVA: Yalpi rentabellik|NRXS (NeurAxis Inc) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Helius Medical Technologies, Inc.|Yalpi rentabellik Passage Bio Inc.|Yalpi foyda marjasi bionomics.com.au NEUP|Yalpi marja NERV|Yalpi marja Athira Pharma Inc (ATHA)|Yalpi marja ADXN (Addex Therapeutics Ltd.)|ALZN: Sotuvning yalpi rentabelligi|CYCN - Yalpi rentabellik|Yalpi foyda marjasi Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Yalpi foyda bo'yicha rentabellik|Sotuvning yalpi marjinal rentabelligi Cortigent, Inc. CRGT|Yalpi rentabellik Avenue Therapeutics, Inc.|Yalpi foyda bo'yicha rentabellik BrainStorm Cell Therapeutics Inc. (BCLI)|Yalpi rentabellik Cara Therapeutics, Inc (CARA)|Yalpi foyda koeffitsiyenti ELYM|Yalpi rentabellik Intra-Cellular ITCI|LBPH: Sotuvning yalpi rentabelligi|MRNS - Yalpi rentabellik|NKGen Biotech, Inc. (NKGN) - Yalpi foyda bo'yicha rentabellik|neurobopharma.com (NRBO) - Yalpi rentabellik|SAGE: Yalpi foyda koeffitsiyenti|Yalpi rentabellik Synaptogenix, Inc.|Yalpi rentabellik TRVN|Yalpi marja VIGL|Yalpi marja anewmeds.com (WENA)|Yalpi marja CERE (cerevel.com)